Fatty acid synthase 1 (FAS I) from Mycobacterium. tuberculosis (Mtb) is an essential protein and a promising drug target. FAS I is a multi-functional, multi-domain protein that is organized as a large (1.9 MDa) homohexameric complex. Acyl intermediates produced during fatty acid elongation are attached covalently to an acyl carrier protein (ACP) domain. This domain is activated by the transfer of a 4'-Phosphopantetheine (4'-PP, also termed P-pant) group from CoA to ACP catalyzed by a 4'-PP transferase, termed acyl carrier protein synthase (AcpS). In order to obtain an activated FAS I in E. coli, we transformed E. coli with tagged Mtb fas1 and acpS genes encoded by a separate plasmid.
Introduction
M. tuberculosis (Mtb) possesses a unique lipid-rich cell wall that confers virulence, persistence and drug resistance. The important components of Mtb cell wall are α -alkyl-β-hydroxyl C80-90 fatty acids termed mycolic acids, and several polyketides (Pk) [1] [2] [3] [4] . Several steps in mycolic acid biosynthesis were identified as drug targets for first-line anti-tuberculosis agents [5] . Mycobacteria unlike other prokaryotes or eukaryotes possess two types of fatty acid synthase systems, FAS I and FAS II. FAS I elongates acetyl-CoA to C16:0-26:0 fatty acids, the substrate for all subsequent steps of elongation and modifications.
FAS I is a multi-functional, multi-domain protein that is organized as a large (1.9 MDa) homohexameric complex [6, 7] . Several structures of fungal FAS were reported, showing that the homologous fungal FAS is a α 6β6 heterododecamer complex of 2.6 MDa which forms a barrel-shaped assembly with D3 symmetry. It has two reaction chambers, each containing three full sets of active sites that catalyze the entire acyl elongation reaction cycle, and are confined by a central wheel and two domes [8] [9] [10] . The mycobacterial FAS I is organized as a head to tail fusion of theα and β units of the fungal FAS [7] . The structure of Mycobacterium smegmatis (M. smegmatis) FAS was shown to resemble a minimized version of the fungal FAS with much larger openings in the reaction chambers. These architectural features of the mycobacterial FAS may be important for mycolic acid processing and condensing enzymes that further modify the precursors produced by FAS I [7] .
The acyl intermediates produced during the fatty acid elongation process are attached covalently to an acyl carrier protein (ACP) domain of FAS I [9, 11] .
The ACP domain is positioned between the ketoreductase (KR) domain and the malonylpalmitoyl transferase (MPT) domain and is activated through the transfer of a P-pant group from CoA to an ACP catalyzed by a 4'-PP transferase (PPTase) enzyme designated AcpS [7, 11] . The Mtb acpS gene (Rv2523c) is located downstream of fas (Rv2524c). It was shown that the fas and acpS genes are part of the same transcription unit forming a fas1-acpS operon under the control of FasR, an essential transcription regulator [12] . The functional association of AcpS of Mtb with FAS I is further supported by the structure-function organization of the analogous yeast FAS I, which possesses a PPTase domain -as part of the α unit of its α /β dodecamer complex [10, 13] and which activates the ACP domain of the α subunit of the yeast FAS I complex [9, 10, 13] . However, it is not clear how the fungal PPTase domain on the α unit accesses the ACP domain which is far apart. It was suggested that the larger openings of mycobacterial FAS I allow easier access of AcpS to the ACP domain [7] .
Mtb fas1 was shown to be an essential gene and FAS I function was shown to be inhibited by pyrazinamide (PZA) analogs and pyrazinoic acid [14, 15] . Pyrazinamide is a first line antituberculous drug and an indispensable component for the shortest curative regimen [16] .
Thus, Mtb FAS I is a promising drug target against tuberculosis. Development of systems to obtain a recombinant active Mtb FAS I is a prerequisite for assays of drug binding and activity and for structure-function analysis.
So far, production of active Mtb FAS I was accomplished using the non-pathogenic strain M.
smegmatis [17] . However, fas1 gene of this strain was not fused to any tag, and thus sufficient purity of the protein required for structural studies has been challenging.
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Herein, we show that sequential co-expression of Mtb AcpS and FAS I in E.coli followed by gentle purification of FAS I, results in binding of P-pant to a conserved serine residue of Mtb FAS I yielding an active hexameric FAS I complex.
Materials and Methods

Cloning of a recombinant Mtb fas1 into pET100 D-Topo
A recombinant His tagged Mtb fas1 was amplified from the plasmid pYUB955 (pMV206 plasmid bearing Mtb fas1) [14] using the primers HKNF and XbaR (Table 1) with Phusion NEB The reaction was conducted at 99ºC for 30 s and then run for 35 two-step cycles in a temperature of 99ºC for 15 s and annealing and extension of 72ºC for 5.5 min with final extension at 72ºC for 10 min. The 10 kb PCR products were cloned into pET100 D-TOPO vector (Invitrogen-Thermo Fisher Scientific). Following transformation into DH5α E. coli, ampicillin resistant colonies were grown and the plasmids were purified and sequenced verifying the presence of the full sequence of Mtb fas1 ORF. The resultant plasmid, designated pMT100-fas1, was used for all further steps described here.
Construction of the Strep-Flag-fas1 fusion plasmid
A Strep tag followed by Flag tag cassette was inserted onto the N-terminus of Mtb fas1 in the expression vector pMT100-fas1. The DNA linker, harboring the cassette, was generated by annealing the two complementary primers, Strep-FlagF and Strep-FlagR, both phosphorylated at the 5'-end (Table 1) . Annealing was performed by incubation of 1µM of each primer in a 0.2 ml tube placed into a PCR thermo block adjusted to 95 o C for 5 min. Following the heating stage, the temperature was gradually reduced to ambient temperature. The double-stranded linker generated, harboring sticky ends at both ends for cloning into an NdeI site. The linker was then ligated into pMT100-fas1 vector digested with NdeI and dephosphorylated. Correct orientation and integrity of the Strep-Flag insertion into pMT100-fas1 were confirmed by PCR (Table 1 ) and DNA sequencing. The resulting vector was designated pMT100-Strep-
Construction of AcpS expression vector controlled by arabinose induction
pACYCDuet-1 derivative vector harboring the arabinose control elements was constructed first. The arabinose control elements (araC repressor and BAD promoter) were amplified from the expression vector pBAD/gIII A (Invitrogen-Thermo Fisher Scientific) and inserted into the NarI and NcoI sites of the expression vector pACYCDuet-1, thus removing most of lacI gene and the T7 promoter from the first multiple cloning site. The resulting vector was designated pACYCAra. The acpS gene was amplified by using acpsF and acpsR primers (Table 1). pACYCAra vector and the PCR product harboring acpS were each digested with DNase I (Roche) and lysed with a French press at 900 PSI. The lysate was centrifuged for 1 hr at 150,000 g. FAS I was precipitated from the lysate in two steps with 20% and 50% ammonium sulfate by overnight incubation and centrifuged for 20 min at 150,000 g. Precipitated 2700 was used for comparison and is described in the supporting information (S method).
Sample preparation for mass spectrometry
The following purified recombinant FAS I samples were examined: FAS I from M. smegmatis mc 2 2700 purified as described in S method; and the fusion protein Strep-Flag-FAS I expressed in E.coli BL21 DE3 cells with or without expression of AcpS. The proteins were loaded onto an 8% SDS PAGE gel, each showing the band of 326 kDa FAS I monomer. The stained bands associated with FAS I, were sliced and placed in 0.65 ml silicon tubes (PGC Scientific), and destained with 25 mM NH 4 HCO 3 in 50% acetonitrile (ACN) and completely dried. The samples were reduced in with 10 mM DTT in 25 mM NH 4 HCO 3 at 56°C for 1 hr and alkylated with 55 mM iodoacetamide in 25 mM NH 4 HCO 3 in the dark for 45 min at room temperature (RT). The dried gel slices were then washed with 25 mM NH 4 HCO 3 in 50% ACN and dehydrated, followed by trypsin digestion with 12.5 ng/μL trypsin in 25 mM NH 4 HCO 3 at 4°C for 10 min, and followed by overnight incubation at 37°C. The reaction was quenched by adding 1:1 volume of trifluoroacetic acid (1%). The eluent was acidified with formic acid, dried and kept at -80˚C for analysis. tion coefficient for NADPH, 6220 molar/cm and then divided by mg of protein used in the reaction and by 10 4 , to account for the reaction volume of 0.1 ml.
Identification of the P-pant group by Mass Spectrometry
EM studies
For negative stain EM, 3.5 μ L of purified FAS I sample at 0.4 mg/ml concentration was applied to glow-discharged, homemade 300 mesh carbon-coated copper TEM grids for 30 sec. 1A) . A band from SDS PAGE gel was submitted to analysis by mass spectrometry following tryptic digest that confirmed its identity as Mtb This migration profile through superpose 6 column ( Fig 1B) is in agreement with an assembled large hexameric complex as examined by EM. In some preparations, the size exclusion profile using superpose 6 column, exhibited two peaks. One peak migrated at 11.47 ml and a second peak migrated as a smaller complex at 12.7 ml. Both peaks correspond to pure FAS I as shown by SDS PAGE but only the 11.47 ml peak exhibited hexameric structures in EM 1 3 and enzymatic activity. It is likely that the protein migrating at 12.7 ml are incompletely assembled FAS I complexes.
Confirmation of P-pant binding to FAS I
To identify the P-pant group binding to serine as a validation of FAS I activation by AcpS, we conducted a bottom proteomic analysis of a tryptic digested gel band. Identification of the modified peptide was performed using a specialized search engine and was confirmed by two distinct measures: the first is MS3 of the supposedly pantetheinylacetamide ejection ion, producing indicative ions of its fragments, which was inspected manually based on the preceding findings of Meier JL et al [19] . The second is manual inspection of the fragmentation spectra of the peptide itself. Expression of FAS I without Mtb AcpS did not yield any peptides bearing P-pant group on Serine 1808 (Fig 2A) . We identified a single P-pant modification site in the activated FAS I expressed in E. coli, on serine 1808 ( Fig 2B) , as was observed for Mtb 
FAS I activity
We utilized spectrophotometric assay of NADPH oxidation resulting in decrease in absorbance at 340 nm. This is a commonly used indirect assay for the study of fatty acid synthesis and elongation. A decrease in 340-nm absorbance was shown only for the AcpS-activated FAS I (Fig. 3A) bearing P-pant. The release of free CoA (yielding free thiol groups), as predicted from malonyl CoA and acetyl CoA binding to ACP during fatty acid synthesis and elongation, was observed using the Ellman's assay resulting in increased absorbance at 412 nm (Fig. 3B ). FAS activity in both assays was dependent on Acetyl CoA and was inhibited by addition of 5-Cl-PZA, a specific inhibitor of FAS I ( Fig 3A) .
FAS I activity was observed only for the hexameric fraction of FAS I following superpose 6 elution (data not shown). We quantified the specific activity as the consumption of NADPH in order to assess the assembly state of the complex. The purified sample was first observed by negative stain EM ( Fig 4A) . Fig 4B) . Plunge-frozen samples at liquid nitrogen temperatures are less prone to artifacts because they are hydrated, and the contrast results from the organic material rather than from heavy metal stain. A data set of 1906 FAS I complexes was manually picked from cryo-TEM images and classified in 2D. Class averages clearly show 3-fold symmetry in the top views, as well as the expected tilted views (Fig 4B inset) . We note that the data set lacks side views, likely because of preferential absorbance of the cavity opening to the carbon. red -absorbance at 260nm, pink -injection point). B. Coomassie blue stained 6%/15% SDS PAGE of 11.4ml peak from (A). 
Discussion
